| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rett Syndrome | 73 | 2023 | 262 | 12.110 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 38 | 2023 | 291 | 3.170 |
Why?
|
| Prader-Willi Syndrome | 5 | 2022 | 69 | 2.000 |
Why?
|
| Electroencephalography | 26 | 2021 | 898 | 1.360 |
Why?
|
| Angelman Syndrome | 6 | 2022 | 78 | 1.320 |
Why?
|
| Sleep Wake Disorders | 7 | 2022 | 348 | 1.200 |
Why?
|
| Mental Retardation, X-Linked | 7 | 2024 | 94 | 1.180 |
Why?
|
| Sleep | 10 | 2022 | 413 | 1.160 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2021 | 413 | 1.130 |
Why?
|
| Polysomnography | 8 | 2022 | 155 | 1.120 |
Why?
|
| Epilepsy | 7 | 2022 | 883 | 1.100 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2022 | 82 | 1.070 |
Why?
|
| Child | 101 | 2023 | 29154 | 1.060 |
Why?
|
| Growth Disorders | 8 | 2012 | 218 | 1.040 |
Why?
|
| Child, Preschool | 75 | 2022 | 16273 | 0.940 |
Why?
|
| Bone Density | 3 | 2014 | 476 | 0.890 |
Why?
|
| Glutamates | 4 | 2023 | 130 | 0.830 |
Why?
|
| Adolescent | 77 | 2022 | 31252 | 0.820 |
Why?
|
| Scoliosis | 5 | 2018 | 139 | 0.790 |
Why?
|
| Disorders of Excessive Somnolence | 3 | 2022 | 35 | 0.720 |
Why?
|
| Spasms, Infantile | 11 | 1994 | 165 | 0.670 |
Why?
|
| Glutamic Acid | 1 | 2019 | 309 | 0.600 |
Why?
|
| Mutation | 25 | 2023 | 15179 | 0.590 |
Why?
|
| Folic Acid | 3 | 2010 | 349 | 0.580 |
Why?
|
| Osteocalcin | 2 | 2014 | 87 | 0.560 |
Why?
|
| Infant | 50 | 2023 | 13310 | 0.560 |
Why?
|
| Alkaline Phosphatase | 2 | 2014 | 207 | 0.540 |
Why?
|
| Gastrointestinal Diseases | 4 | 2023 | 589 | 0.530 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 215 | 0.520 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 521 | 0.520 |
Why?
|
| Oligopeptides | 1 | 2017 | 429 | 0.510 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 5 | 2012 | 134 | 0.490 |
Why?
|
| Humans | 147 | 2024 | 261506 | 0.490 |
Why?
|
| Severity of Illness Index | 15 | 2021 | 4320 | 0.470 |
Why?
|
| Female | 102 | 2023 | 141928 | 0.470 |
Why?
|
| Autistic Disorder | 7 | 2009 | 319 | 0.460 |
Why?
|
| Collagen Type I | 1 | 2014 | 204 | 0.460 |
Why?
|
| Autonomic Nervous System | 2 | 2005 | 72 | 0.460 |
Why?
|
| Gastrectomy | 1 | 2016 | 451 | 0.460 |
Why?
|
| Betaine | 2 | 2010 | 27 | 0.440 |
Why?
|
| Osteogenesis | 1 | 2014 | 271 | 0.430 |
Why?
|
| Nutrition Disorders | 1 | 2012 | 57 | 0.430 |
Why?
|
| Vitamin D | 2 | 2011 | 261 | 0.410 |
Why?
|
| Cerebral Cortex | 5 | 2005 | 621 | 0.400 |
Why?
|
| Calcium, Dietary | 2 | 2014 | 56 | 0.400 |
Why?
|
| Caregivers | 5 | 2023 | 677 | 0.400 |
Why?
|
| Double-Blind Method | 9 | 2023 | 2588 | 0.390 |
Why?
|
| Bone and Bones | 1 | 2014 | 619 | 0.390 |
Why?
|
| Parents | 5 | 2024 | 998 | 0.390 |
Why?
|
| Vitamins | 1 | 2011 | 157 | 0.380 |
Why?
|
| Chromosome Duplication | 3 | 2020 | 157 | 0.380 |
Why?
|
| Prevalence | 10 | 2019 | 3260 | 0.380 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 115 | 0.370 |
Why?
|
| Dietary Supplements | 2 | 2011 | 558 | 0.370 |
Why?
|
| Tourette Syndrome | 4 | 2008 | 130 | 0.360 |
Why?
|
| Body Size | 1 | 2009 | 70 | 0.340 |
Why?
|
| Young Adult | 21 | 2021 | 21445 | 0.340 |
Why?
|
| Growth | 1 | 2009 | 117 | 0.340 |
Why?
|
| Nutritional Support | 1 | 2009 | 80 | 0.340 |
Why?
|
| Somnambulism | 1 | 2008 | 2 | 0.330 |
Why?
|
| Night Terrors | 1 | 2008 | 3 | 0.330 |
Why?
|
| Age Factors | 15 | 2020 | 5377 | 0.330 |
Why?
|
| Attention | 2 | 2008 | 281 | 0.330 |
Why?
|
| Peptides | 1 | 2014 | 1479 | 0.320 |
Why?
|
| Surveys and Questionnaires | 10 | 2024 | 5687 | 0.320 |
Why?
|
| Mathematics | 1 | 2008 | 136 | 0.320 |
Why?
|
| Quality of Life | 10 | 2022 | 4532 | 0.320 |
Why?
|
| Gastrostomy | 1 | 2009 | 180 | 0.310 |
Why?
|
| Human Growth Hormone | 1 | 2008 | 82 | 0.310 |
Why?
|
| Epilepsies, Partial | 6 | 2006 | 111 | 0.300 |
Why?
|
| Gene Duplication | 4 | 2019 | 421 | 0.300 |
Why?
|
| Phenotype | 17 | 2021 | 6295 | 0.300 |
Why?
|
| Adrenocorticotropic Hormone | 6 | 1994 | 156 | 0.290 |
Why?
|
| Neuropsychological Tests | 6 | 2020 | 1178 | 0.290 |
Why?
|
| Adult | 39 | 2022 | 77950 | 0.290 |
Why?
|
| Regression Analysis | 4 | 2011 | 1546 | 0.280 |
Why?
|
| Male | 54 | 2022 | 123000 | 0.280 |
Why?
|
| Fractures, Bone | 1 | 2008 | 291 | 0.270 |
Why?
|
| Tetrahydrofolates | 1 | 2005 | 21 | 0.270 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2005 | 60 | 0.270 |
Why?
|
| Brain | 9 | 2005 | 4113 | 0.270 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 211 | 0.260 |
Why?
|
| Absorptiometry, Photon | 3 | 2014 | 239 | 0.260 |
Why?
|
| Cognition | 3 | 2008 | 968 | 0.260 |
Why?
|
| Cerebrospinal Fluid | 1 | 2005 | 120 | 0.250 |
Why?
|
| Psychometrics | 4 | 2024 | 937 | 0.250 |
Why?
|
| Body Composition | 1 | 2008 | 595 | 0.250 |
Why?
|
| Longitudinal Studies | 8 | 2019 | 1945 | 0.250 |
Why?
|
| Chromosomes, Human, X | 4 | 2023 | 192 | 0.250 |
Why?
|
| Nutritional Status | 2 | 2011 | 337 | 0.230 |
Why?
|
| Walking | 3 | 2022 | 277 | 0.230 |
Why?
|
| Intellectual Disability | 7 | 2009 | 1032 | 0.230 |
Why?
|
| Anticonvulsants | 4 | 2015 | 431 | 0.220 |
Why?
|
| Epilepsy, Frontal Lobe | 1 | 2002 | 11 | 0.220 |
Why?
|
| Narcolepsy | 1 | 2022 | 5 | 0.220 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 2002 | 101 | 0.210 |
Why?
|
| Epilepsy, Generalized | 2 | 2006 | 71 | 0.210 |
Why?
|
| Abnormalities, Multiple | 6 | 2019 | 998 | 0.210 |
Why?
|
| Anti-Anxiety Agents | 1 | 2022 | 90 | 0.200 |
Why?
|
| Hand | 2 | 2019 | 170 | 0.200 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2020 | 228 | 0.190 |
Why?
|
| Psychomotor Performance | 1 | 2002 | 233 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 17 | 6 | 2007 | 641 | 0.190 |
Why?
|
| Child Behavior | 2 | 2020 | 243 | 0.190 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2020 | 69 | 0.190 |
Why?
|
| Gray Matter | 1 | 2020 | 63 | 0.180 |
Why?
|
| Gastroesophageal Reflux | 1 | 2023 | 334 | 0.180 |
Why?
|
| X Chromosome | 3 | 2004 | 339 | 0.180 |
Why?
|
| Stereotyped Behavior | 2 | 2019 | 35 | 0.180 |
Why?
|
| Cognition Disorders | 2 | 2018 | 786 | 0.180 |
Why?
|
| Esophageal Motility Disorders | 1 | 1999 | 9 | 0.180 |
Why?
|
| Hypnotics and Sedatives | 3 | 2007 | 218 | 0.180 |
Why?
|
| Evidence-Based Medicine | 1 | 2005 | 1085 | 0.180 |
Why?
|
| Calcium | 1 | 2006 | 1537 | 0.180 |
Why?
|
| Motor Activity | 2 | 2020 | 693 | 0.170 |
Why?
|
| Oropharynx | 1 | 1999 | 74 | 0.170 |
Why?
|
| Biliary Tract Diseases | 1 | 2019 | 61 | 0.170 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 4314 | 0.160 |
Why?
|
| Body Mass Index | 6 | 2018 | 2203 | 0.160 |
Why?
|
| Metabolome | 1 | 2021 | 344 | 0.160 |
Why?
|
| Parathyroid Hormone | 2 | 2011 | 194 | 0.160 |
Why?
|
| Rare Diseases | 1 | 2021 | 351 | 0.160 |
Why?
|
| Respiration Disorders | 1 | 2018 | 45 | 0.160 |
Why?
|
| White Matter | 1 | 2020 | 195 | 0.160 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 324 | 0.160 |
Why?
|
| Reproducibility of Results | 4 | 2024 | 6009 | 0.150 |
Why?
|
| Health Status | 1 | 2021 | 590 | 0.150 |
Why?
|
| Organ Size | 2 | 2020 | 690 | 0.150 |
Why?
|
| Prospective Studies | 11 | 2022 | 12873 | 0.150 |
Why?
|
| Ataxia | 3 | 1987 | 176 | 0.150 |
Why?
|
| Seizures | 4 | 2018 | 989 | 0.150 |
Why?
|
| Puberty | 2 | 2014 | 104 | 0.150 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 417 | 0.140 |
Why?
|
| Urinary Retention | 1 | 2016 | 21 | 0.140 |
Why?
|
| Energy Metabolism | 3 | 1998 | 992 | 0.140 |
Why?
|
| Urethral Obstruction | 1 | 2016 | 56 | 0.140 |
Why?
|
| Prednisone | 4 | 1991 | 984 | 0.140 |
Why?
|
| Treatment Outcome | 8 | 2023 | 32848 | 0.140 |
Why?
|
| Pediatrics | 1 | 2005 | 1141 | 0.140 |
Why?
|
| Retrospective Studies | 10 | 2019 | 37905 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 4938 | 0.130 |
Why?
|
| Sodium Channel Blockers | 1 | 2015 | 37 | 0.130 |
Why?
|
| Diet | 2 | 2014 | 1440 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2022 | 2803 | 0.130 |
Why?
|
| Phosphorus, Dietary | 1 | 2014 | 4 | 0.130 |
Why?
|
| Age of Onset | 3 | 2015 | 827 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2011 | 231 | 0.130 |
Why?
|
| Repressor Proteins | 2 | 2018 | 1664 | 0.130 |
Why?
|
| Diet Records | 1 | 2014 | 77 | 0.120 |
Why?
|
| Chromosome Aberrations | 4 | 2011 | 1960 | 0.120 |
Why?
|
| Body Height | 4 | 2012 | 231 | 0.120 |
Why?
|
| Monitoring, Physiologic | 4 | 1994 | 502 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2016 | 224 | 0.120 |
Why?
|
| Dementia | 3 | 1987 | 453 | 0.120 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2018 | 591 | 0.120 |
Why?
|
| Gene Dosage | 2 | 2007 | 829 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 4988 | 0.120 |
Why?
|
| Renal Insufficiency | 1 | 2016 | 321 | 0.120 |
Why?
|
| Sleep Stages | 3 | 2008 | 78 | 0.110 |
Why?
|
| Population Surveillance | 2 | 1995 | 627 | 0.110 |
Why?
|
| Tetrabenazine | 3 | 1988 | 41 | 0.110 |
Why?
|
| Dietary Proteins | 1 | 2014 | 241 | 0.110 |
Why?
|
| Infant Nutrition Disorders | 1 | 2012 | 30 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 907 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2017 | 9244 | 0.110 |
Why?
|
| Child Nutrition Disorders | 1 | 2012 | 77 | 0.100 |
Why?
|
| Dairy Products | 1 | 2011 | 38 | 0.100 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 96 | 0.100 |
Why?
|
| Child Behavior Disorders | 1 | 2012 | 68 | 0.100 |
Why?
|
| Critical Pathways | 1 | 2012 | 149 | 0.100 |
Why?
|
| Constipation | 2 | 2023 | 177 | 0.100 |
Why?
|
| Bone Diseases | 1 | 2012 | 143 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2016 | 6207 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 778 | 0.100 |
Why?
|
| Movement Disorders | 3 | 1998 | 232 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 4892 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2015 | 473 | 0.100 |
Why?
|
| Substance P | 2 | 2001 | 71 | 0.100 |
Why?
|
| Biomarkers | 3 | 2014 | 5047 | 0.100 |
Why?
|
| Homovanillic Acid | 2 | 2009 | 21 | 0.100 |
Why?
|
| Health Surveys | 1 | 2012 | 402 | 0.100 |
Why?
|
| Hydroxyindoleacetic Acid | 2 | 2009 | 25 | 0.100 |
Why?
|
| Sleep, REM | 7 | 2014 | 28 | 0.100 |
Why?
|
| Anxiety | 3 | 2022 | 1179 | 0.090 |
Why?
|
| Apnea | 3 | 1986 | 30 | 0.090 |
Why?
|
| Evoked Potentials | 3 | 2002 | 190 | 0.090 |
Why?
|
| Genotype | 4 | 2018 | 4109 | 0.090 |
Why?
|
| Body Weight | 4 | 2012 | 1293 | 0.090 |
Why?
|
| Body Fluid Compartments | 1 | 2009 | 21 | 0.090 |
Why?
|
| Databases, Factual | 2 | 2016 | 2218 | 0.090 |
Why?
|
| Amines | 1 | 2009 | 85 | 0.090 |
Why?
|
| Fundoplication | 1 | 2009 | 56 | 0.090 |
Why?
|
| Point Mutation | 2 | 2004 | 769 | 0.090 |
Why?
|
| Infant, Newborn | 8 | 2010 | 8223 | 0.080 |
Why?
|
| Sex Factors | 2 | 2010 | 2139 | 0.080 |
Why?
|
| Gait | 2 | 2020 | 165 | 0.080 |
Why?
|
| Biomechanical Phenomena | 2 | 2020 | 338 | 0.080 |
Why?
|
| Registries | 2 | 1995 | 2170 | 0.080 |
Why?
|
| Middle Aged | 13 | 2022 | 86204 | 0.080 |
Why?
|
| Exercise Test | 2 | 2020 | 312 | 0.080 |
Why?
|
| Syndrome | 7 | 2007 | 1351 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2020 | 6100 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2011 | 854 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 1491 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1990 | 311 | 0.080 |
Why?
|
| Terminology as Topic | 1 | 2010 | 414 | 0.080 |
Why?
|
| Anxiety Disorders | 1 | 2014 | 666 | 0.080 |
Why?
|
| Long QT Syndrome | 2 | 2015 | 92 | 0.080 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 14889 | 0.080 |
Why?
|
| Child Abuse | 2 | 1988 | 193 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2016 | 1225 | 0.080 |
Why?
|
| Immersion | 1 | 1987 | 7 | 0.080 |
Why?
|
| Respiration | 2 | 1987 | 447 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2008 | 2307 | 0.070 |
Why?
|
| Drowning | 1 | 1987 | 31 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 3343 | 0.070 |
Why?
|
| Calcium Isotopes | 1 | 2006 | 8 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 5539 | 0.070 |
Why?
|
| Brain Diseases | 2 | 1987 | 403 | 0.070 |
Why?
|
| Phosphorus | 1 | 2006 | 65 | 0.070 |
Why?
|
| HLA Antigens | 1 | 1988 | 546 | 0.070 |
Why?
|
| Afferent Pathways | 1 | 2005 | 64 | 0.070 |
Why?
|
| Carbamazepine | 3 | 1995 | 49 | 0.070 |
Why?
|
| Behavior | 2 | 2002 | 103 | 0.070 |
Why?
|
| Reference Values | 2 | 2005 | 1099 | 0.070 |
Why?
|
| Developmental Disabilities | 2 | 2006 | 674 | 0.070 |
Why?
|
| Adaptation, Psychological | 2 | 2017 | 764 | 0.070 |
Why?
|
| Folic Acid Deficiency | 1 | 2005 | 54 | 0.060 |
Why?
|
| Anthropometry | 3 | 2022 | 269 | 0.060 |
Why?
|
| Sequence Deletion | 2 | 2005 | 875 | 0.060 |
Why?
|
| Memory | 2 | 2012 | 429 | 0.060 |
Why?
|
| Leucovorin | 1 | 2005 | 332 | 0.060 |
Why?
|
| Trisomy | 1 | 2005 | 231 | 0.060 |
Why?
|
| Hydrocortisone | 1 | 2006 | 388 | 0.060 |
Why?
|
| Respiratory Mechanics | 1 | 2005 | 173 | 0.060 |
Why?
|
| Adenoidectomy | 1 | 2005 | 63 | 0.060 |
Why?
|
| DNA Methylation | 2 | 2011 | 2669 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2007 | 745 | 0.060 |
Why?
|
| Sudden Infant Death | 1 | 1984 | 33 | 0.060 |
Why?
|
| Prognosis | 4 | 2019 | 21713 | 0.060 |
Why?
|
| Translocation, Genetic | 1 | 1990 | 1245 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2009 | 769 | 0.060 |
Why?
|
| Blood-Brain Barrier | 1 | 2005 | 238 | 0.060 |
Why?
|
| Creatinine | 1 | 2006 | 531 | 0.060 |
Why?
|
| Disease Progression | 4 | 2019 | 6682 | 0.060 |
Why?
|
| Tonsillectomy | 1 | 2005 | 102 | 0.060 |
Why?
|
| Mosaicism | 1 | 2005 | 272 | 0.060 |
Why?
|
| Exons | 2 | 2005 | 1328 | 0.060 |
Why?
|
| Biogenic Amines | 3 | 1989 | 15 | 0.060 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2009 | 81 | 0.060 |
Why?
|
| Chromosome Deletion | 2 | 2006 | 1005 | 0.060 |
Why?
|
| Cytokines | 1 | 2012 | 2809 | 0.060 |
Why?
|
| Arousal | 1 | 1983 | 120 | 0.050 |
Why?
|
| Heterozygote | 1 | 2006 | 1020 | 0.050 |
Why?
|
| Texas | 3 | 2008 | 6311 | 0.050 |
Why?
|
| Socialization | 1 | 2002 | 16 | 0.050 |
Why?
|
| Electrocardiography | 2 | 2002 | 1145 | 0.050 |
Why?
|
| Neurons | 3 | 2009 | 2287 | 0.050 |
Why?
|
| Risk Factors | 5 | 2019 | 17523 | 0.050 |
Why?
|
| Heart Rate | 1 | 2005 | 737 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2009 | 862 | 0.050 |
Why?
|
| Enteric Nervous System | 1 | 2001 | 36 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 4744 | 0.050 |
Why?
|
| Digestive System | 1 | 2001 | 114 | 0.050 |
Why?
|
| Brain Chemistry | 2 | 2000 | 145 | 0.050 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2021 | 95 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 362 | 0.050 |
Why?
|
| Behavior Therapy | 1 | 2004 | 298 | 0.050 |
Why?
|
| Videotape Recording | 2 | 1993 | 74 | 0.050 |
Why?
|
| Pyridines | 1 | 2007 | 1244 | 0.050 |
Why?
|
| Schools | 1 | 2002 | 233 | 0.050 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2000 | 63 | 0.050 |
Why?
|
| Standard of Care | 1 | 2022 | 243 | 0.050 |
Why?
|
| Gene Expression | 2 | 2016 | 3570 | 0.050 |
Why?
|
| Melatonin | 1 | 2000 | 46 | 0.050 |
Why?
|
| HIV Infections | 1 | 2012 | 2134 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2002 | 552 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 2508 | 0.040 |
Why?
|
| Drug Administration Schedule | 3 | 2007 | 3472 | 0.040 |
Why?
|
| Gastric Emptying | 1 | 1999 | 94 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2021 | 490 | 0.040 |
Why?
|
| Video Recording | 2 | 2006 | 267 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 4821 | 0.040 |
Why?
|
| Energy Intake | 2 | 1999 | 515 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2005 | 787 | 0.040 |
Why?
|
| Child Development | 4 | 1991 | 255 | 0.040 |
Why?
|
| Wakefulness | 3 | 1991 | 150 | 0.040 |
Why?
|
| Munchausen Syndrome | 2 | 1988 | 4 | 0.040 |
Why?
|
| North America | 2 | 2010 | 314 | 0.040 |
Why?
|
| Deglutition | 1 | 1999 | 171 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2000 | 330 | 0.040 |
Why?
|
| Chromosome Banding | 2 | 2005 | 256 | 0.040 |
Why?
|
| Feces | 1 | 2021 | 770 | 0.040 |
Why?
|
| Television | 1 | 1998 | 74 | 0.040 |
Why?
|
| Foot | 1 | 1998 | 104 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2020 | 498 | 0.040 |
Why?
|
| Phenytoin | 2 | 2015 | 71 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2007 | 2232 | 0.040 |
Why?
|
| Dominance, Cerebral | 2 | 1994 | 81 | 0.040 |
Why?
|
| Penetrance | 1 | 2016 | 126 | 0.040 |
Why?
|
| Reaction Time | 2 | 1987 | 234 | 0.030 |
Why?
|
| Mice | 4 | 2016 | 34495 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 1994 | 209 | 0.030 |
Why?
|
| Linear Models | 2 | 2016 | 1085 | 0.030 |
Why?
|
| Movement | 1 | 2019 | 556 | 0.030 |
Why?
|
| Communication | 1 | 2002 | 876 | 0.030 |
Why?
|
| Hydrotherapy | 1 | 1995 | 4 | 0.030 |
Why?
|
| Hypnosis | 1 | 1995 | 14 | 0.030 |
Why?
|
| Hyperventilation | 1 | 2015 | 19 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 777 | 0.030 |
Why?
|
| Alpha Rhythm | 1 | 1995 | 14 | 0.030 |
Why?
|
| Radiation Protection | 2 | 1973 | 205 | 0.030 |
Why?
|
| Menarche | 1 | 2014 | 50 | 0.030 |
Why?
|
| Brain Stem | 3 | 2000 | 175 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 1995 | 95 | 0.030 |
Why?
|
| Propranolol | 1 | 2015 | 156 | 0.030 |
Why?
|
| Animals | 5 | 2016 | 59536 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 337 | 0.030 |
Why?
|
| Tomography, X-Ray | 1 | 1973 | 13 | 0.030 |
Why?
|
| Death, Sudden | 1 | 1994 | 59 | 0.030 |
Why?
|
| Naltrexone | 1 | 1994 | 87 | 0.030 |
Why?
|
| Incidence | 2 | 1995 | 5673 | 0.030 |
Why?
|
| Tic Disorders | 2 | 1984 | 65 | 0.030 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 1973 | 77 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2015 | 144 | 0.030 |
Why?
|
| Radiation Monitoring | 1 | 1973 | 49 | 0.030 |
Why?
|
| Population Growth | 1 | 1993 | 7 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 2483 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1987 | 7551 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 7702 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 1994 | 409 | 0.030 |
Why?
|
| Growth Charts | 1 | 2012 | 14 | 0.030 |
Why?
|
| Emotions | 1 | 2017 | 562 | 0.030 |
Why?
|
| Clinical Trials as Topic | 4 | 2006 | 3719 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 2007 | 1471 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 7222 | 0.030 |
Why?
|
| United States | 2 | 2023 | 15433 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2015 | 323 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1993 | 418 | 0.030 |
Why?
|
| Infant Food | 1 | 1992 | 89 | 0.030 |
Why?
|
| Decision Trees | 1 | 2012 | 178 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 1973 | 232 | 0.030 |
Why?
|
| Aged | 4 | 2019 | 70117 | 0.030 |
Why?
|
| Depression | 1 | 2022 | 1715 | 0.030 |
Why?
|
| Family | 1 | 2016 | 736 | 0.030 |
Why?
|
| Reference Standards | 1 | 2012 | 339 | 0.030 |
Why?
|
| Natural History | 1 | 2010 | 1 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 1973 | 462 | 0.020 |
Why?
|
| Quality Control | 1 | 2012 | 457 | 0.020 |
Why?
|
| Breast Feeding | 1 | 1992 | 239 | 0.020 |
Why?
|
| Executive Function | 1 | 2012 | 160 | 0.020 |
Why?
|
| Lipotropic Agents | 1 | 2010 | 6 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1992 | 164 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1995 | 500 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 1993 | 230 | 0.020 |
Why?
|
| Chromatin | 1 | 2016 | 942 | 0.020 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 1992 | 192 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 2352 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 383 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2016 | 1819 | 0.020 |
Why?
|
| Basal Ganglia Diseases | 1 | 1990 | 29 | 0.020 |
Why?
|
| Vitamin B Complex | 1 | 2010 | 51 | 0.020 |
Why?
|
| Radiation Dosage | 2 | 1978 | 1014 | 0.020 |
Why?
|
| Methysergide | 1 | 1989 | 5 | 0.020 |
Why?
|
| Methyltyrosines | 1 | 1989 | 4 | 0.020 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2009 | 30 | 0.020 |
Why?
|
| Forecasting | 1 | 1993 | 694 | 0.020 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 39 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2009 | 73 | 0.020 |
Why?
|
| Evoked Potentials, Auditory | 2 | 1987 | 50 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 437 | 0.020 |
Why?
|
| Genomic Imprinting | 1 | 2010 | 194 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 1516 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 1084 | 0.020 |
Why?
|
| Kidney | 2 | 1999 | 2146 | 0.020 |
Why?
|
| Bradycardia | 2 | 1986 | 70 | 0.020 |
Why?
|
| Ammonia | 1 | 1989 | 88 | 0.020 |
Why?
|
| Family Health | 1 | 2009 | 325 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 980 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 621 | 0.020 |
Why?
|
| Neurocognitive Disorders | 1 | 1989 | 69 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 4298 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2015 | 1863 | 0.020 |
Why?
|
| Research Design | 2 | 1993 | 1544 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2010 | 574 | 0.020 |
Why?
|
| Data Collection | 1 | 2011 | 620 | 0.020 |
Why?
|
| Genetic Testing | 2 | 2006 | 1589 | 0.020 |
Why?
|
| Mortality | 1 | 2010 | 343 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2007 | 128 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2009 | 417 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2012 | 1033 | 0.020 |
Why?
|
| Phenobarbital | 1 | 1986 | 48 | 0.020 |
Why?
|
| Auditory Perception | 1 | 1987 | 35 | 0.020 |
Why?
|
| Electrophysiology | 2 | 2000 | 333 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2005 | 2283 | 0.020 |
Why?
|
| Brain Damage, Chronic | 1 | 1985 | 37 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2007 | 700 | 0.020 |
Why?
|
| Language Disorders | 1 | 2005 | 26 | 0.020 |
Why?
|
| Home Care Services | 1 | 1986 | 92 | 0.020 |
Why?
|
| Atrophy | 1 | 1986 | 261 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2005 | 226 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 9180 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2007 | 1163 | 0.020 |
Why?
|
| Bottle Feeding | 1 | 1984 | 36 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2012 | 1586 | 0.020 |
Why?
|
| Resuscitation | 1 | 1986 | 223 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 4549 | 0.020 |
Why?
|
| Coma | 1 | 1984 | 61 | 0.010 |
Why?
|
| Myelin Basic Protein | 1 | 1984 | 85 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 6942 | 0.010 |
Why?
|
| Gonads | 2 | 1973 | 53 | 0.010 |
Why?
|
| Karyotyping | 1 | 2005 | 1022 | 0.010 |
Why?
|
| Introns | 1 | 2005 | 432 | 0.010 |
Why?
|
| Community Health Services | 1 | 2005 | 126 | 0.010 |
Why?
|
| Nervous System | 1 | 1984 | 165 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 1984 | 276 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 1984 | 129 | 0.010 |
Why?
|
| Pedigree | 2 | 2000 | 1890 | 0.010 |
Why?
|
| Sympathetic Fibers, Postganglionic | 1 | 2001 | 6 | 0.010 |
Why?
|
| Obesity | 1 | 2015 | 2884 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2001 | 28 | 0.010 |
Why?
|
| Recurrence | 2 | 1989 | 4758 | 0.010 |
Why?
|
| Infant, Premature, Diseases | 1 | 1984 | 245 | 0.010 |
Why?
|
| Catecholamines | 1 | 2001 | 101 | 0.010 |
Why?
|
| Hypoxia | 1 | 1984 | 443 | 0.010 |
Why?
|
| Infant, Premature | 1 | 1986 | 787 | 0.010 |
Why?
|
| Algorithms | 1 | 1992 | 3890 | 0.010 |
Why?
|
| COP9 Signalosome Complex | 1 | 2000 | 72 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2006 | 795 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 12926 | 0.010 |
Why?
|
| Mesencephalon | 1 | 2000 | 58 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 2000 | 64 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1985 | 2315 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 5710 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2000 | 151 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 6150 | 0.010 |
Why?
|
| Survival Rate | 1 | 1993 | 12221 | 0.010 |
Why?
|
| Thalamus | 1 | 2000 | 132 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 2000 | 187 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 4917 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 2000 | 256 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2000 | 395 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1978 | 660 | 0.010 |
Why?
|
| Astrocytes | 1 | 2000 | 368 | 0.010 |
Why?
|
| Antibodies | 1 | 2000 | 838 | 0.010 |
Why?
|
| Spleen | 1 | 1999 | 676 | 0.010 |
Why?
|
| Audiometry | 1 | 1996 | 24 | 0.010 |
Why?
|
| Mass Screening | 1 | 2005 | 1509 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1996 | 245 | 0.010 |
Why?
|
| Eye Abnormalities | 1 | 1996 | 118 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2000 | 1152 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 2403 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 1995 | 136 | 0.010 |
Why?
|
| Radiography | 1 | 1978 | 1904 | 0.010 |
Why?
|
| Methods | 1 | 1973 | 189 | 0.010 |
Why?
|
| Hippocampus | 1 | 2000 | 915 | 0.010 |
Why?
|
| Lithium | 1 | 1973 | 71 | 0.010 |
Why?
|
| Air Pollution, Radioactive | 1 | 1973 | 3 | 0.010 |
Why?
|
| Mobile Health Units | 1 | 1973 | 34 | 0.010 |
Why?
|
| Cephalometry | 1 | 1993 | 39 | 0.010 |
Why?
|
| Aging | 1 | 2001 | 1582 | 0.010 |
Why?
|
| Heart | 1 | 1999 | 1223 | 0.010 |
Why?
|
| Neural Conduction | 1 | 1992 | 112 | 0.010 |
Why?
|
| Proteins | 1 | 2000 | 1963 | 0.010 |
Why?
|
| Head | 1 | 1993 | 249 | 0.010 |
Why?
|
| Microcomputers | 1 | 1991 | 36 | 0.010 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1992 | 182 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1992 | 401 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1991 | 119 | 0.010 |
Why?
|
| Multigene Family | 1 | 1992 | 425 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 7548 | 0.010 |
Why?
|
| alpha-Methyltyrosine | 1 | 1989 | 4 | 0.010 |
Why?
|
| Barbiturates | 1 | 1989 | 9 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 1991 | 310 | 0.010 |
Why?
|
| Dihydropteridine Reductase | 1 | 1989 | 4 | 0.010 |
Why?
|
| Neopterin | 1 | 1989 | 13 | 0.010 |
Why?
|
| Models, Statistical | 1 | 1995 | 1171 | 0.010 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1989 | 50 | 0.010 |
Why?
|
| Liver | 1 | 1999 | 2961 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1994 | 732 | 0.000 |
Why?
|
| Random Allocation | 1 | 1989 | 703 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1991 | 544 | 0.000 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1985 | 24 | 0.000 |
Why?
|
| Sural Nerve | 1 | 1985 | 54 | 0.000 |
Why?
|
| Motor Skills | 1 | 1985 | 107 | 0.000 |
Why?
|
| Respiratory Center | 1 | 1984 | 10 | 0.000 |
Why?
|
| Evoked Potentials, Visual | 1 | 1984 | 39 | 0.000 |
Why?
|
| Receptors, Dopamine | 1 | 1984 | 42 | 0.000 |
Why?
|
| DNA | 1 | 1992 | 2693 | 0.000 |
Why?
|
| Light | 1 | 1984 | 245 | 0.000 |
Why?
|
| Carbon Dioxide | 1 | 1984 | 313 | 0.000 |
Why?
|
| Necrosis | 1 | 1984 | 580 | 0.000 |
Why?
|
| Meningeal Neoplasms | 1 | 1984 | 441 | 0.000 |
Why?
|